318 related articles for article (PubMed ID: 26260436)
21. Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential.
Lee JS; Shukla S; Kim JA; Kim M
PLoS One; 2015; 10(2):e0118552. PubMed ID: 25714482
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological Characterization of Levorphanol, a G-Protein Biased Opioid Analgesic.
Le Rouzic V; Narayan A; Hunkle A; Marrone GF; Lu Z; Majumdar S; Xu J; Pan YX; Pasternak GW
Anesth Analg; 2019 Feb; 128(2):365-373. PubMed ID: 29649035
[TBL] [Abstract][Full Text] [Related]
23. The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward.
Khroyan TV; Polgar WE; Cami-Kobeci G; Husbands SM; Zaveri NT; Toll L
J Pharmacol Exp Ther; 2011 Mar; 336(3):952-61. PubMed ID: 21177476
[TBL] [Abstract][Full Text] [Related]
24. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
Vanderah TW; Largent-Milnes T; Lai J; Porreca F; Houghten RA; Menzaghi F; Wisniewski K; Stalewski J; Sueiras-Diaz J; Galyean R; Schteingart C; Junien JL; Trojnar J; Rivière PJ
Eur J Pharmacol; 2008 Mar; 583(1):62-72. PubMed ID: 18282565
[TBL] [Abstract][Full Text] [Related]
25. Divergent Response to Cannabinoid Receptor Stimulation in High and Low Stress-Induced Analgesia Mouse Lines Is Associated with Differential G-Protein Activation.
Lesniak A; Chmielewska D; Poznanski P; Bujalska-Zadrozny M; Strzemecka J; Sacharczuk M
Neuroscience; 2019 Apr; 404():246-258. PubMed ID: 30794845
[TBL] [Abstract][Full Text] [Related]
26. Isolation and characterization of two
Menéndez-Perdomo IM; Facchini PJ
J Biol Chem; 2020 Feb; 295(6):1598-1612. PubMed ID: 31914404
[TBL] [Abstract][Full Text] [Related]
27. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
[TBL] [Abstract][Full Text] [Related]
28. In vitro binding affinities of a series of flavonoids for μ-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice.
Higgs J; Wasowski C; Loscalzo LM; Marder M
Neuropharmacology; 2013 Sep; 72():9-19. PubMed ID: 23624290
[TBL] [Abstract][Full Text] [Related]
29. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
Bhalla S; Zhang Z; Patterson N; Gulati A
Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
[TBL] [Abstract][Full Text] [Related]
30. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
[TBL] [Abstract][Full Text] [Related]
32. Nelumbo nucifera promotes non-rapid eye movement sleep by regulating GABAergic receptors in rat model.
Jo K; Kim S; Hong KB; Suh HJ
J Ethnopharmacol; 2021 Mar; 267():113511. PubMed ID: 33148434
[TBL] [Abstract][Full Text] [Related]
33. Nuciferine, extracted from Nelumbo nucifera Gaertn, inhibits tumor-promoting effect of nicotine involving Wnt/β-catenin signaling in non-small cell lung cancer.
Liu W; Yi DD; Guo JL; Xiang ZX; Deng LF; He L
J Ethnopharmacol; 2015 May; 165():83-93. PubMed ID: 25698245
[TBL] [Abstract][Full Text] [Related]
34. Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.
Zhang LS; Wang J; Chen JC; Tao YM; Wang YH; Xu XJ; Chen J; Xu YG; Xi T; Hu XW; Wang YJ; Liu JG
Acta Pharmacol Sin; 2015 May; 36(5):565-71. PubMed ID: 25816912
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
36. K-targeted strategy for isolation of phenolic alkaloids of Nelumbo nucifera Gaertn by counter-current chromatography using lysine as a pH regulator.
Wang Y; Zhang L; Zhou H; Guo X; Wu S
J Chromatogr A; 2017 Mar; 1490():115-125. PubMed ID: 28236459
[TBL] [Abstract][Full Text] [Related]
37. Chemical constituents from Nelumbo nucifera leaves and their anti-obesity effects.
Ahn JH; Kim ES; Lee C; Kim S; Cho SH; Hwang BY; Lee MK
Bioorg Med Chem Lett; 2013 Jun; 23(12):3604-8. PubMed ID: 23642481
[TBL] [Abstract][Full Text] [Related]
38. Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose range.
Codd EE; Ma J; Zhang SP; Stone DJ; Colburn RW; Brandt MR; Chevalier KM; Zhu Y; Peng S; Cai C; Acton PD; Flores CM
Pharmacol Biochem Behav; 2010 Aug; 96(2):130-5. PubMed ID: 20438745
[TBL] [Abstract][Full Text] [Related]
39. Affinities of dihydrocodeine and its metabolites to opioid receptors.
Schmidt H; Vormfelde Sv; Klinder K; Gundert-Remy U; Gleiter CH; Skopp G; Aderjan R; Fuhr U
Pharmacol Toxicol; 2002 Aug; 91(2):57-63. PubMed ID: 12420793
[TBL] [Abstract][Full Text] [Related]
40. Thienorphine: receptor binding and behavioral effects in rhesus monkeys.
Li JX; Becker GL; Traynor JR; Gong ZH; France CP
J Pharmacol Exp Ther; 2007 Apr; 321(1):227-36. PubMed ID: 17220427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
